Abstract
Objectives: MDM2 gene amplification is associated with well-differentiated (WDL) and dedifferentiated liposarcomas (DDL). Using fluorescent in situ hybridization (FISH), we sought to characterize various patterns of MDM2 amplification among the morphologic spectrum of liposarcoma. Methods: Forty-six cases of liposarcoma in various sites were examined and included 22 WDLs, 14 DLLs, and 10 negative control subjects. Results: The MDM2 amplification ratio (MDM2/CEP12) was lower in WDL (10.2) compared with ddl (18.3) cases (P = .0000002). An amplification ratio of 16 showed optimal sensitivity (0.86) and specificity (0.96) as a cutoff point for progression to DDL. Borderline areas, defined as tumors with increased cellularity and atypia but with preserved lipomatous differentiation, showed a significantly higher MDM2 ratio (17.5; P = .0007) compared with WDL. Central (retroperitoneal and intra-abdominal) tumors also showed a significantly higher MDM2 ratio than peripheral ones (P = .02). Conclusions: Differences in MDM2 amplification profiles among liposarcomas could help further define and predict progression to high-grade neoplasia.
Author supplied keywords
Cite
CITATION STYLE
Ware, P. L., Snow, A. N., Gvalani, M., Pettenati, M. J., & Qasem, S. A. (2014). MDM2 copy numbers in well-differentiated and dedifferentiated liposarcoma. American Journal of Clinical Pathology, 141(3), 334–341. https://doi.org/10.1309/AJCPLYU89XHSNHQO
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.